Sepio Capital LP Has $3.38 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Sepio Capital LP raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,412 shares of the healthcare conglomerate’s stock after buying an additional 526 shares during the quarter. Sepio Capital LP’s holdings in UnitedHealth Group were worth $3,376,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of UNH. Norges Bank bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $5,802,231,000. International Assets Investment Management LLC lifted its stake in shares of UnitedHealth Group by 53,573.1% in the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after purchasing an additional 2,348,107 shares during the period. Jennison Associates LLC raised its stake in UnitedHealth Group by 49.3% during the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock worth $1,904,670,000 after buying an additional 1,195,352 shares during the period. Mawer Investment Management Ltd. grew its holdings in shares of UnitedHealth Group by 75.0% in the third quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock valued at $1,014,002,000 after acquiring an additional 862,024 shares in the last quarter. Finally, California Public Employees Retirement System lifted its position in shares of UnitedHealth Group by 35.9% during the fourth quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock worth $1,627,311,000 after acquiring an additional 815,822 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

UNH stock traded down $8.66 during trading on Friday, hitting $508.17. 2,414,748 shares of the company’s stock traded hands, compared to its average volume of 4,169,007. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The stock has a fifty day moving average price of $488.88 and a two-hundred day moving average price of $511.10. The stock has a market capitalization of $467.71 billion, a price-to-earnings ratio of 31.43, a price-to-earnings-growth ratio of 1.51 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.26 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Wells Fargo & Company lowered their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. TD Cowen reduced their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Bank of America reaffirmed a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Stephens reissued an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 8th. Finally, Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.